Povidone Iodine
Iodine, a halogen element, has been a crucial antiseptic and antimicrobial agent in medical and hygienic applications for centuries. Iodine is a potent pathogen killer, capable of penetrating cells and degrading functional proteins and nucleic acids to kill microorganisms. However, in its elemental form, iodine is a volatile, non-polar substance with poor water solubility, which presents challenges in its effective use and processing as an antiseptic. This underscores the necessity for iodine to be bound to a carrier polymer.
The most commonly utilized and optimal carrier polymer is PVP (polyvinylpyrrolidone, also known as povidone) K30. This water-soluble polymer exhibits a distinctive capacity to form complexes with an array of substances, functioning as a carrier through hydrogen bonding with iodine. PVP serves to enhance the stability, solubility, controlled release, and wide utilization of iodine.
The PVP-I (polyvinylpyrrolidone-iodine) complex is based on a liquid-solid reaction process, which is a fundamental process known worldwide. This process involves the dissolution of PVP in a solvent, followed by the addition of iodine and subsequent processing, and finally, drying. Nevertheless, the disadvantages inherent to this process render it an unfavorable production method:
The team at Quality Povidone Pharmatech Group, established in 2024 in Turkey/Adana, has been actively working for two years and after conducting the required analyzes on American standards has developed a reactor capable of producing high-quality and stable PVP-I in a solid form with the best modern technologies suitable for povidone iodine powder.
This approach is economically viable and provides the desired yield, with benefits such as ease of production, faster production, higher iodine content, lower costs, environmental friendliness due to the absence of solvents, and minimal energy loss as the dry product is obtained directly. The constantly updated reactor is now available for purchase after reaching its final form.
Following a comprehensive analysis of the shortcomings associated with the liquid method and two years of rigorous experimentation, the production line for povidone iodine powder by the solid method was industrialized and developed. The solid method was ultimately selected due to the following reasons:
The utilization of solvents and iodine solutions has the potential to pose health risks to workers if the requisite safety precautions are not taken and safety protocols are not strictly adhered to, with the objective of preventing accidents and injuries during the production process. In light of these constraints, the location of the production line and the design of the production line were based on occupational health and safety criteria.